Healthcare Holding B.V. Gilde Sells 3,900 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 3,900 shares of the firm’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $22.60, for a total value of $88,140.00. Following the sale, the insider directly owned 2,208,307 shares in the company, valued at $49,907,738.20. The trade was a 0.18% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.62, for a total value of $15,404.22.
• On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.61, for a total value of $463,866.76.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total value of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.64, for a total value of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total transaction of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.71, for a total transaction of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total transaction of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Trading Down 0.0%

Shares of NYSE:SI opened at $22.21 on Wednesday. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $24.59. The company has a quick ratio of 8.92, a current ratio of 10.71 and a debt-to-equity ratio of 0.12. The company’s fifty day simple moving average is $21.10 and its 200 day simple moving average is $16.66. The firm has a market cap of $462.41 million and a price-to-earnings ratio of -11.57.

Shoulder Innovations (NYSE:SI) last announced its earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). The company had revenue of $17.18 million during the quarter. Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%. As a group, research analysts forecast that Shoulder Innovations, Inc. will post -1.9 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently issued reports on SI. Piper Sandler reiterated an “overweight” rating and set a $25.00 price objective (up from $19.00) on shares of Shoulder Innovations in a report on Friday, August 7th. UBS Group upped their price target on Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Weiss Ratings upgraded shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday, August 3rd. Finally, BTIG Research boosted their price objective on shares of Shoulder Innovations from $24.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Five investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $25.50.

Institutional Trading of Shoulder Innovations

Hedge funds have recently made changes to their positions in the business. Deerfield Management Company L.P. acquired a new position in shares of Shoulder Innovations during the 3rd quarter worth approximately $6,056,000. Alyeska Investment Group L.P. acquired a new stake in Shoulder Innovations during the 3rd quarter valued at $5,667,000. Vanguard Group Inc. bought a new position in Shoulder Innovations during the third quarter worth $1,836,000. Roubaix Capital LLC increased its holdings in shares of Shoulder Innovations by 61.9% in the first quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock valued at $3,736,000 after purchasing an additional 98,305 shares during the last quarter. Finally, Millennium Management LLC acquired a new position in shares of Shoulder Innovations in the fourth quarter valued at $1,316,000.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.